Search - tctmd.com

Displaying 81 - 100 of 102

Sort: Relevancy | Date

News Conference News AHA 2015

Varenicline Helps ACS Patients Quit Smoking, But Effect Wanes

Todd Neale

November 12, 2015

News Conference News AHA 2015

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

Yael L. Maxwell

November 10, 2015

News Conference News AHA 2015

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Todd Neale

November 10, 2015

News Conference News AHA 2015

Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower

Yael L. Maxwell

November 08, 2015

News Conference News AHA 2014

Regional STEMI Care Systems Improve Treatment Times

Yael L. Maxwell

November 18, 2014

News Conference News AHA 2014

AVOIDing Oxygen in Suspected STEMI Tied to Smaller Infarcts, Less Recurrent MI

Yael L. Maxwell

November 18, 2014

News Conference News AHA 2014

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Yael L. Maxwell

November 17, 2014

Presentation AHA 2014

Efficacy and safety of vorapaxar in NSTE ACS patients undergoing non-cardiac surgery

Presenter: S. van Diepen

November 16, 2014

News Conference News AHA 2014

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2014

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

Yael L. Maxwell

November 16, 2014

News Conference News AHA 2013

Risk of Kidney Injury Not Affected by High-Potency Statin Regimen in ACS Patients

Yael L. Maxwell

November 20, 2013

News Conference News AHA 2013

STREAM: Pre-hospital Fibrinolysis Strategy as Safe as Primary PCI at 1 Year in STEMI

Yael L. Maxwell

November 18, 2013

News Conference News AHA 2012

Evidence Continues to Support Dabigatran Treatment in A-fib

November 06, 2012

Presentation AHA 2012

The TIME Randomized Trial: Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear on Timing of Delivery following AMI on Left Ventricular Function

Presenter: Jay H. Traverse

November 05, 2012

Presentation AHA 2012

Intracoronary infusion of BM-MNC early or late after AMI: 4 month results of the SWISS-AMI trial

Presenter: Daniel S?rder

November 05, 2012

Presentation AHA 2012

Results of Exenatide Myocardial Protection In REvascularization (EMPIRE) Study

Presenter: Weon Kim

November 04, 2012

News Conference News AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Jason Kahn

November 04, 2012

Presentation AHA 2012

First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial: The TRILOGY ACS — Platelet Function Substudy

Presenter: Paul A. Gurbel

November 04, 2012

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Conference News

MI FREEE: Free Post-MI Drugs Reduce Events, Costs

November 15, 2011

Advertisement

Varenicline Helps ACS Patients Quit Smoking, But Effect Wanes

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

Most Drug Discontinuations in PEGASUS-TIMI 54 Related to Dyspnea, Bleeding

Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower

Regional STEMI Care Systems Improve Treatment Times

AVOIDing Oxygen in Suspected STEMI Tied to Smaller Infarcts, Less Recurrent MI

Registry: Newer P2Y12 Inhibitors Reduce Stent Thrombosis, Mortality Over Clopidogrel

Efficacy and safety of vorapaxar in NSTE ACS patients undergoing non-cardiac surgery

Vorapaxar Safe in NSTE-ACS But Bleeding Risk Merits 6-Month Delay Before Noncardiac Surgery

Extending Clopidogrel Past 1 Year Improves Outcomes in DES, But Not BMS Patients

Risk of Kidney Injury Not Affected by High-Potency Statin Regimen in ACS Patients

STREAM: Pre-hospital Fibrinolysis Strategy as Safe as Primary PCI at 1 Year in STEMI

Evidence Continues to Support Dabigatran Treatment in A-fib

The TIME Randomized Trial: Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear on Timing of Delivery following AMI on Left Ventricular Function

Intracoronary infusion of BM-MNC early or late after AMI: 4 month results of the SWISS-AMI trial

Results of Exenatide Myocardial Protection In REvascularization (EMPIRE) Study

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

First Large-Scale Platelet Function Evaluation in an Acute Coronary Syndromes Trial: The TRILOGY ACS — Platelet Function Substudy

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

MI FREEE: Free Post-MI Drugs Reduce Events, Costs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content